Evidence map›Paper›PMID 41007761›Full record

ArticleBiomedicines2025

Proteomic Profiling of EUS-FNA Samples Differentiates Pancreatic Adenocarcinoma from Mass-Forming Chronic Pancreatitis.

Casandra Teodorescu, Ioana-Ecaterina Pralea, Maria-Andreea Soporan, Rares Ilie Orzan, Maria Iacobescu, Andrada Seicean, Cristina-Adela Iuga

Abstract read
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Casandra TeodorescuDepartment of Gastroenterology, "Prof. Dr. Octavian Fodor" Regional Institute of Gastroenterology and Hepatology, 400394 Cluj-Napoca, Romania.ORCID 0000-0003-0882-8403
Ioana-Ecaterina PraleaPersonalized Medicine and Rare Diseases Department, MEDFUTURE-Institute for Biomedical Research "Iuliu Hațieganu" University of Medicine and Pharmacy, Louis Pasteur Street 6, 400349 Cluj-Napoca, Romania.ORCID 0000-0002-9516-0474
Maria-Andreea SoporanPersonalized Medicine and Rare Diseases Department, MEDFUTURE-Institute for Biomedical Research "Iuliu Hațieganu" University of Medicine and Pharmacy, Louis Pasteur Street 6, 400349 Cluj-Napoca, Romania.ORCID 0000-0002-0080-9972
Rares Ilie OrzanDepartment of Gastroenterology, "Prof. Dr. Octavian Fodor" Regional Institute of Gastroenterology and Hepatology, 400394 Cluj-Napoca, Romania.ORCID 0000-0002-8638-496X
Maria IacobescuPersonalized Medicine and Rare Diseases Department, MEDFUTURE-Institute for Biomedical Research "Iuliu Hațieganu" University of Medicine and Pharmacy, Louis Pasteur Street 6, 400349 Cluj-Napoca, Romania.ORCID 0000-0002-0659-8926
Andrada SeiceanDepartment of Gastroenterology, "Prof. Dr. Octavian Fodor" Regional Institute of Gastroenterology and Hepatology, 400394 Cluj-Napoca, Romania.ORCID 0000-0002-5809-1334
Cristina-Adela IugaPersonalized Medicine and Rare Diseases Department, MEDFUTURE-Institute for Biomedical Research "Iuliu Hațieganu" University of Medicine and Pharmacy, Louis Pasteur Street 6, 400349 Cluj-Napoca, Romania.ORCID 0000-0002-0345-0993

Funding

Iuliu Hatieganu' University of Medicine and Pharmacy, Cluj-Napoca Grant number 4472/01.10.2019
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic pancreatitisEUS-FNAlabel-free proteomicsmass-forming pancreatitismass spectrometrypancreatic ductal adenocarcinoma

Identifiers

PMID41007761
PMCPMC12467292

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.